Provided by Tiger Trade Technology Pte. Ltd.

Amarin Corp PLC

14.75
+0.66004.68%
Post-market: 14.750.00000.00%16:10 EST
Volume:89.39K
Turnover:1.30M
Market Cap:306.69M
PE:-3.52
High:14.99
Open:14.32
Low:14.14
Close:14.09
52wk High:20.90
52wk Low:7.08
Shares:20.79M
Float Shares:18.76M
Volume Ratio:1.19
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1875
EPS(LYR):-3.9998
ROE:-17.41%
ROA:-2.46%
PB:0.67
PE(LYR):-3.69

Loading ...

Company Profile

Company Name:
Amarin Corp PLC
Exchange:
NASDAQ
Establishment Date:
1989
Employees:
- -
Office Location:
One Central Plaza,5th Floor,36 Dame Street,Dublin,Co. Dublin,Ireland
Zip Code:
D02 K7K5
Fax:
- -
Introduction:
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Directors

Name
Position
Aaron D. Berg
Director,President and Chief Executive Officer
Odysseas Kostas
Director and Chairman of the Board
Diane Sullivan
Director
Keith L. Horn
Director
Louis Sterling III
Director
Michael Torok
Director
Oliver O'Connor
Director
Patrice Bonfiglio
Director
Paul Cohen
Director

Shareholders

Name
Position
Aaron D. Berg
Director,President and Chief Executive Officer
David Keenan
Executive Vice President, Chief Operating Officer
Peter L. Fishman
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
Jonathan N. Provoost
Executive Vice President, Chief Legal & Compliance Officer and Secretary
Steven B. Ketchum
Executive Vice President, President of R&D and Chief Scientific Officer